Amendment and Mail Process Complete

INREBIC

IMPACT BIOMEDICINES, INC.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88207119 FILING DATE 11/27/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY TM ATTORNEY NOT ASSIGNED L.O. ASSIGNED NONE

PUB INFORMATION

RUN DATE 01/11/2019
PUB DATE N/A
STATUS 630-NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
STATUS DATE 12/14/2018
LITERAL MARK ELEMENT INREBIC

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT INREBIC
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG YES

CURRENT OWNER INFORMATION

PARTY TYPE 11-SUBSEQUENT OWNER BEFORE PUBLICATION
NAME IMPACT BIOMEDICINES, INC.
ADDRESS 86 MORRIS AVENUE
SUMMIT, NJ 07901
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT The color(s) blue and grey is/are claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of a prism in the shape of a V made up varying colors of blue and grey over the letter "E" of "INREBIC" in blue block lettering.
OWNER OF US REG NOS 4931750   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/10/2019 AMPX O APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED 007
01/09/2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP 006
01/09/2019 ALIE A ASSIGNED TO LIE 005
01/04/2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED 004
12/15/2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
12/14/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
11/30/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Camille M. Miller
CORRESPONDENCE ADDRESS CAMILLE M. MILLER
COZEN O'CONNOR
1650 MARKET STREET
SUITE 1650
PHILADELPHIA, PA 19103
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Celgene Corporation
ADDRESS 86 Morris Avenue
Summit, NJ 07901
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed